Literature DB >> 11130970

Mice, the motor system, and human motor neuron pathology.

S J Nicholson1, A S Witherden, M Hafezparast, J E Martin, E M Fisher.   

Abstract

Motor neurons are among some of the most unusual cells in the body becaue of their immense size and their role as the critical link between the motor centers of the brain and the muscles. In addition to their intrinsic biological interest, it is vital that we gain a better understanding of these cells and their pathology, since motor neuron degenerative diseases are lethal disorders that affect young and old and are relatively common. For example, one form of spinal muscular atrophy (SMA) is the most common genetic killer of children in the developed world. Amyotrophic lateral sclerosis (ALS), another form of motor neuron degeneration, is the third most common neurodegenerative cause of adult death, after Alzheimer's disease and Parkinson's disease, and is significantly more common than multiple sclerosis (Motor Neurone Disease Association 1998). Currently, approximately 1 in 500 people in England and Wales who die have a form of motor neuron disease (Motor Neurone Disease Association 1998). Each year, 5000 Americans are diagnosed with ALS, and of these, 10% are under 40 years old. Mouse models of motor neuron degeneration are essential for understanding the causes and mechanisms of motor neuron pathology. These mice are yielding important information that will ultimately lead to treatments and potentially cures for these diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11130970     DOI: 10.1007/s003350010205

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  9 in total

Review 1.  Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Authors:  Robert P Picone; Debra A Kendall
Journal:  Mol Endocrinol       Date:  2015-04-13

Review 2.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis.

Authors:  Arif Y Shaikh; Lee J Martin
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

4.  Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy.

Authors:  Terry P Maddatu; Sean M Garvey; David G Schroeder; Thomas G Hampton; Gregory A Cox
Journal:  Hum Mol Genet       Date:  2004-04-06       Impact factor: 6.150

5.  A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.

Authors:  Abraham Acevedo-Arozena; Bernadett Kalmar; Shafa Essa; Thomas Ricketts; Peter Joyce; Rosie Kent; Claire Rowe; Andy Parker; Anna Gray; Majid Hafezparast; Julian R Thorpe; Linda Greensmith; Elizabeth M C Fisher
Journal:  Dis Model Mech       Date:  2011-05-02       Impact factor: 5.758

6.  Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs.

Authors:  Sara Geneletti; Valentina Gallo; Miquel Porta; Muin J Khoury; Paolo Vineis
Journal:  Emerg Themes Epidemiol       Date:  2011-06-09

Review 7.  Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.

Authors:  Fiammetta Vanoli; Paola Rinchetti; Francesca Porro; Valeria Parente; Stefania Corti
Journal:  J Cell Mol Med       Date:  2015-06-20       Impact factor: 5.310

Review 8.  Cut wires: The Electrophysiology of Regenerated Tissue.

Authors:  Alexis L Lowe; Nitish V Thakor
Journal:  Bioelectron Med       Date:  2021-02-23

Review 9.  The endocannabinoid system: a putative role in neurodegenerative diseases.

Authors:  Giuseppe Di Iorio; Matteo Lupi; Fabiola Sarchione; Ilaria Matarazzo; Rita Santacroce; Filippo Petruccelli; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Int J High Risk Behav Addict       Date:  2013-12-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.